SUPN Stock Performance and Key Statistics

SUPN has a current P/E ratio of -152.29

The SUPN stock has a trailing twelve month price-to sales (P/S) ratio of 0.01 while its price-to-book (P/B) value is 0.

SUPN's price-to-free-cashflow (P/FCF) ratio is 15.5, an indicator that is currently being trending upward.

Based on SUPN's recent bid, its distance from 20 days simple moving average is 10.68%. It is 6.53% apart from 50 days simple moving average, and it is 30.89% apart from 200 days simple moving average.

The 52-week high for SUPN is $57.65 which is -10.7% away from the current price level whereas the distance of that from the 52-week low of $29.16 stands at 76.54%.

The performance of SUPN stock was not encouraging with most of its significant price indicators in green. Supernus Pharmaceuticals, Inc.(NASDAQ: SUPN) shares have moved upward +4.46% or $2.20 in the latest trading session and have gained 42.37% year-to-date (YTD). The stock has gained nearly 42.33% over the past year. After moving 11.82% over the trailing 3-month period, the stock is 59.48% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 10.69% a week and 14.65% a month.

The current 14-day RSI for SUPN stock is 68.86. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Supernus Pharmaceuticals, Inc. (SUPN) has a 14-day ATR of 1.68.

After closing at $49.28 with 55.97M of its shares outstanding, the current enterprise value of SUPN is roughly 1.62B.

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is up 42.33% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 12.87%. SUPN stock price is also up 42.37% on its value in year-to-date trading.

The number outstanding shares of SUPN is 55.97M, and of these 87.16% shares are freely available for trading. On average, SUPN stock has traded 852.16K shares per day for the past 10 days. A total of 1.35M shares changed hands during the last trading session with the average session volume of 827.37K shares.